지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2021.4
- 수록면
- 85 - 91 (7page)
- DOI
- https://doi.org/10.3904/kjm.2021.96.2.85
이용수
초록· 키워드
오류제보하기
Diabetes is one of the important risk factors in cardiovascular disease associated with atherosclerosis, and cardiovascular disease is the leading cause of death in patients with diabetes mellitus. Recent randomized placebo-controlled cardiovascular outcome trials of all new antidiabetic drugs have linked SGLT-2 inhibitors and GLP1-agonists to not only increased cardiovascular stability but significant reduction of cardiovascular disease. These results have led to preferential selection of the most effective and beneficial antidiabetic drugs with the evidence of cardiovascular safety and efficacy. Herein, we address cardiovascular stability and the effectiveness of antidiabetic drugs, focusing on recently developed ones.
목차
등록된 정보가 없습니다.
참고문헌 (27)
참고문헌 신청
American Diabetes Association / 2021 / 10. Cardiovascular disease and risk management: standards of medical care in diabetes-2021 / Diabetes Care 44(Suppl 1):S125~S150
Food and Drug Administration / Guidance for industry: diabetes mellitus―evaluating cardiovascular risk in new antidiabetic therapies to treat type 2 diabetes
Lincoff AM / 2007 / Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus : a meta-analysis of randomized trials / JAMA 298:1180~1188
Bonaventura A / 2019 / Pharmacologic strategies to reduce cardiovascular disease in type 2 diabetes mellitus : focus on SGLT-2 inhibitors and GLP-1 receptor agonists / J Intern Med 286:16~31
Dicker D / 2011 / DPP-4 inhibitors: impact on glycemic control and cardiovascular risk factors / Diabetes Care 34(Suppl 2):S276~S278
Food and Drug Administration / Guidance for industry: diabetes mellitus―evaluating cardiovascular risk in new antidiabetic therapies to treat type 2 diabetes
Lincoff AM / 2007 / Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus : a meta-analysis of randomized trials / JAMA 298:1180~1188
Bonaventura A / 2019 / Pharmacologic strategies to reduce cardiovascular disease in type 2 diabetes mellitus : focus on SGLT-2 inhibitors and GLP-1 receptor agonists / J Intern Med 286:16~31
Dicker D / 2011 / DPP-4 inhibitors: impact on glycemic control and cardiovascular risk factors / Diabetes Care 34(Suppl 2):S276~S278
함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Diabetes Drugs and Cardiovascular Safety
Endocrinology and Metabolism
2016 .01
-
Effects of Thiazolidinedione and New Antidiabetic Agents on Stroke
대한뇌졸중학회지
2019 .01
-
Cardiovascular Outcome Trials of Sodium Glucose Cotransporter 2 Inhibitor and Its Possible Cardioprotective Mechanism
지질·동맥경화학회지
2018 .01
-
Socioeconomic Disparities in Cardiovascular Diseases in South Korea
성인간호학회 학술대회
2017 .05
-
새로운 당뇨병 치료제
대한의사협회지
2017 .01
-
Resistance Exercise and Cardiovascular Disease in Diabetes Mellitus
Journal of Obesity & Metabolic Syndrome
2022 .06
-
Letter to the Editor: Impact of Cardiovascular Risk Factors and Cardiovascular Diseases on Outcomes in Patients Hospitalized with COVID-19 in Daegu Metropolitan City
Journal of Korean Medical Science
2021 .01
-
Modifiable Risk Factors for Cardiovascular Disease in Korea and Japan
Korean Circulation Journal
2021 .01
-
Cardiovascular Risk Prediction in Korean Adults
Korean Journal of Family Medicine
2018 .01
-
여성의 심혈관 질환 예방
Korean Journal of Family Practice
2020 .01
-
Cardiovascular Risk Factors: It's Time to Focus on Variability!
지질·동맥경화학회지
2020 .01
-
Professional Continuous Glucose Monitoring Reveals Nocturnal Hypoglycemia in Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease Treated with Oral Antidiabetics
Korean Journal of Family Medicine
2021 .01
-
미세먼지/황사 건강피해 예방 및 권고지침: 심혈관질환
대한의사협회지
2015 .01
-
노인 심혈관질환의 다약제 포괄관리
대한의사협회지
2024 .07
-
Cardiovascular Risk Factors and Obesity in Adolescents
Korean Circulation Journal
2020 .01
-
Postoperative cardiovascular complication
대한외과학회 학술대회 초록집
2016 .11
-
Ultra-Processed Foods as a Less-Known Risk Factor in Cardiovascular Diseases
Korean Circulation Journal
2022 .01
-
Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association
Diabetes and Metabolism Journal
2017 .01
-
Trends in Cardiovascular Disease Mortality: Can We Prevent PRECISELY?
Korean Circulation Journal
2021 .01
이 논문의 저자 정보
최근 본 자료
댓글(0)
0